drugset / Trial / NCT00225862

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

NCT00225862

Phase 3 Completed 140 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

A 12-week clinical research study to evaluate the tolerability, efficacy and safety of ropinirole compared to placebo(an inactive sugar pill) in the treatment of patients with RLS in the United States.

Timeline

Start
2005-01
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropinirole Small molecule